ArrowHead Pharma (ARWR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec24

HBK Sorce Advisory LLC Acquired Arrowhead Pharmaceuticals Stocks in Q3

11:02

Dec23

Arrowhead Pharmaceuticals Director Adeoye Y. Olukotun Sells Common Stock

23:02

Arrowhead Pharmaceuticals to Attend Two Major Events in January 2026

12:30

Dec16

Arrowhead Pharmaceuticals CEO Sells Company Common Stock

18:15

Dec15

Marex Group Buys Arrowhead Pharmaceuticals Shares in Q2

11:26

Dec11

RBC Raises Arrowhead Pharmaceuticals Target Price to $80

16:10

Schedules & Filings

Schedules

Filings

Nov25

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 256.47 M, Net Income -23.75 M, EPS -0.1741

Aug7

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.77 M, Net Income -175.24 M, EPS -1.2603

May12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 542.71 M, Net Income 370.45 M, EPS 2.75

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change